ConductScience.org, home

Paper41007256

Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy.

Rajneesh and 10 others. Biology (Basel), 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy. Papers, record 41007256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007256

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy.
PubMed
Journal
Biology (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-09-30
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rajneesh
2Tiwari RRahul
3Singh VKVishal Kumar
4Kumar AAwnish
5Mehrotra SSanjana
6Gautam VVibhavhttps://orcid.org/0000-0001-7956-9555
7Neville JFJ F
8Bansal VVyomika
9Pathak RRajivhttps://orcid.org/0000-0001-9133-3983
10Singh AKAkhilesh Kumarhttps://orcid.org/0000-0003-2916-3615
11Kumar RRajiv

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Institute of Eminence GrantBanaras Hindu University, VaranasiPubMed

Source PubMed

Download CSV of grants

References194

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124498219Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients.PLoS One2014https://conductscience.org/library/papers/24498219PubMed
210551740PCNA/AgNOR and Ki-67/AgNOR double staining in oral squamous cell carcinoma.J Oral Pathol Med1999https://conductscience.org/library/papers/10551740PubMed
334502102Hypoxia Pathway Proteins and Their Impact on the Blood Vasculature.Int J Mol Sci2021https://conductscience.org/library/papers/34502102PubMed
435116996TNF-α promotes tumor lymph angiogenesis in head and neck squamous cell carcinoma through regulation of ERK3.Transl Cancer Res2019https://conductscience.org/library/papers/35116996PubMed
516730260Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.Adv Immunol2006https://conductscience.org/library/papers/16730260PubMed
624702237Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease.Antioxid Redox Signal2014https://conductscience.org/library/papers/24702237PubMed
72488320Clinical/technical challenges in adoptive cellular immunotherapy (ACI): the role of cytapheresis.Immunol Ser1989https://conductscience.org/library/papers/2488320PubMed
825962348Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study.Pathol Oncol Res2015https://conductscience.org/library/papers/25962348PubMed
936007522Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα.Cell Metab2022https://conductscience.org/library/papers/36007522PubMed
1031750584Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta-analysis.Head Neck2020https://conductscience.org/library/papers/31750584PubMed
1138398094Mechanisms of Resistance and Therapeutic Perspectives in Immunotherapy for Advanced Head and Neck Cancers.Cancers (Basel)2024https://conductscience.org/library/papers/38398094PubMed
1233211709Density of CD3+ and CD8+ cells in gingivo-buccal oral squamous cell carcinoma is associated with lymph node metastases and survival.PLoS One2020https://conductscience.org/library/papers/33211709PubMed
1331735641Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor.Mol Cell2020https://conductscience.org/library/papers/31735641PubMed
1437099710Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma. A Systematic Review and Meta-analysis.Med Oral Patol Oral Cir Bucal2023https://conductscience.org/library/papers/37099710PubMed
1527160553Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.Sci Rep2016https://conductscience.org/library/papers/27160553PubMed
1628397778Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer.Diagnostics (Basel)2017https://conductscience.org/library/papers/28397778PubMed
1737038210The relationship between sphingosine-1-phosphate receptor 2 and epidermal growth factor in migration and invasion of oral squamous cell carcinoma.Cancer Cell Int2023https://conductscience.org/library/papers/37038210PubMed
1825480554Chemokines in cancer.Cancer Immunol Res2014https://conductscience.org/library/papers/25480554PubMed
1934414241lncRNA DCST1-AS1 Facilitates Oral Squamous Cell Carcinoma by Promoting M2 Macrophage Polarization through Activating NF-κB Signaling.J Immunol Res2021https://conductscience.org/library/papers/34414241PubMed
2025818339Immune evasion in cancer: Mechanistic basis and therapeutic strategies.Semin Cancer Biol2015https://conductscience.org/library/papers/25818339PubMed

See all 194 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42812354Editorial: Integrative OMICS approaches in cancer biology: from molecular mechanisms to precision medicine.Front Oncol2026https://conductscience.org/library/papers/42812354PubMed
42516741Unraveling role of arginine-NO metabolism by targeting HIF-1α signaling in mediating esophageal squamous cell carcinoma.Front Mol Biosci2026https://conductscience.org/library/papers/42516741PubMed
42371183Targeting metabolic reprogramming in HPV-associated oral squamous cell carcinoma: current advances, challenges, and clinical prospects.J Mol Histol2026https://conductscience.org/library/papers/42371183PubMed
41374963Targeted Therapies in Oral and Oropharyngeal Cancer: An Overview of Emerging and Repurposed Agents.Cancers (Basel)2025https://conductscience.org/library/papers/41374963PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007256

GET https://conductscience.org/api/papers/v1/41007256/references?page=2